HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

LIFELONG PROGRESSIVE RETINAL ATROPHIC LESIONS IN A PATIENT WITH PARTIAL ACQUIRED LIPODYSTROPHY (BARRAQUER-SIMONS SYNDROME).

AbstractPURPOSE:
To report a case of lifelong progressive retinal atrophic lesions in a patient with partial acquired lipodystrophy, that is, Barraquer-Simons syndrome.
METHODS:
Case report.
RESULTS:
A 67-year-old female patient with Barraquer-Simons syndrome was referred for progressive visual loss. Barraquer-Simons syndrome is a rare acquired partial lipodystrophy characterized by a loss of subcutaneous fat in the upper half of the body. Fundus examination disclosed posterior atrophic lesions, particularly evident on autofluorescence images, and their progression as compared to a previous examination performed nine years earlier. Multimodal imaging confirmed the posterior atrophic lesions without any associated exudative signs and highlighted the extension of atrophic areas in the periphery.
CONCLUSION:
We here report for the first time a documented progressive retinal atrophy associated with Barraquer-Simons syndrome. Drusen and neovascular complications have already been described in previous reports, but no long-term follow-up was available until the present case to observe such dramatic evolution of the retinal lesions.
AuthorsThibaut Gaboriau, Vincent Rigalleau, Marie-Bénédicte Rougier, Jean-François Korobelnik, Marie-Noëlle Delyfer
JournalRetinal cases & brief reports (Retin Cases Brief Rep) Vol. 16 Issue 1 Pg. 102-105 (Jan 01 2022) ISSN: 1937-1578 [Electronic] United States
PMID31453930 (Publication Type: Case Reports)
Topics
  • Aged
  • Atrophy (diagnostic imaging, pathology)
  • Female
  • Humans
  • Lipodystrophy
  • Multimodal Imaging
  • Retina (diagnostic imaging, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: